Amesite Inc Stock Price, News & Analysis

Amesite (NASDAQ: AMST) announced significant success with its automated sales flow for NurseMagic™ for Teams, an enterprise solution serving home care, home health care, and hospice businesses. The new purchase system has reduced enterprise sales closing time by over 95%, allowing customers to complete subscriptions within minutes of engagement.

The streamlined process enables healthcare organizations to immediately onboard teams to the AI-powered NurseMagic™ platform, which helps reduce documentation burdens and improve workflow efficiency for nurses and caregivers. Enterprise customers can manage subscriptions, control user access, ensure HIPAA compliance, and easily scale by adding licenses as they grow.

According to Amesite, these market segments represent an addressable market exceeding $360 billion annually with over 50,000 U.S. businesses. The company has already secured customers in three key segments and aims to expand across healthcare verticals, contributing to the industry's projected $600 billion AI transformation opportunity by 2034.

Amesite (NASDAQ:AMST), an AI technology company, will be featured on the NASDAQ Tower in Times Square, celebrating recent business achievements. The company's CEO, Dr. Ann Marie Sastry, will attend a media event highlighting the successful launch of NurseMagic™, their proprietary AI app targeting the $130 billion healthcare sector.

NurseMagic™, designed for nursing professionals and home health care workers, has achieved rapid adoption across all 50 U.S. states and 21 countries. The AI-powered application supports daily patient care tasks and career development, featuring tools for creating nursing notes in multiple formats including SOAP, SOAPIER, Narrative, and ISBAR. The company reports strong customer validation through testimonials from paying customers, demonstrating product market fit.

Amesite Inc. (Nasdaq: AMST), an AI technology company, announces its participation in The Microcap Conference 2025 at the Borgata Hotel Spa & Casino in Atlantic City from January 28-30, 2025. CEO Dr. Ann Marie Sastry will deliver a corporate presentation on January 29 at 2:30 PM ET and conduct one-on-one meetings with investors.

The presentation will focus on recent developments of the company's NurseMagic™ app, an AI-powered mobile application designed for nursing professionals and home health care workers. The app aims to streamline daily tasks, enhance efficiency, improve patient communication, and support career development. Dr. Sastry will also discuss the company's growth strategy and monetization plans in both B2C and B2B markets.

Amesite Inc. (Nasdaq: AMST) has announced the closing of its 'best efforts' underwritten public offering, raising approximately $3.6 million through the sale of 1,201,667 shares of common stock at $3.00 per share. Company officers and directors participated in the offering with subscriptions totaling about $1.26 million.

The offering was jointly managed by Laidlaw & Company (UK) and Craft Capital Management The company plans to utilize the net proceeds for general corporate purposes, capital expenditures, working capital, and general and administrative expenses. The offering was conducted under a previously filed and effective shelf registration statement on Form S-3.

Amesite (Nasdaq: AMST) has announced the pricing of its 'best efforts' underwritten public offering of 1,201,667 shares of common stock at $3.00 per share, aiming to raise approximately $3.6 million. Company officers and directors are participating with subscriptions of about $1.26 million.

The offering is expected to close on January 8, 2025, with Laidlaw & Company and Craft Capital Management acting as joint book-running managers. The net proceeds will be used for general corporate purposes, capital expenditures, working capital, and general and administrative expenses.

The offering is being made pursuant to a shelf registration statement on Form S-3 that was declared effective by the SEC on December 18, 2024.

Amesite Inc (Nasdaq: AMST), an AI technology company focusing on B2C and B2B solutions, has announced plans for a 'best efforts' underwritten public offering of common stock and pre-funded warrants. Laidlaw & Company and Craft Capital Management will serve as joint book-running managers for the offering.

The offering will be conducted under a previously filed and effective shelf registration statement (Form S-3, Registration No. 333-282999) from December 18, 2024. The company plans to use the proceeds for general corporate purposes, capital expenditures, working capital, and administrative expenses.

The final terms, size, and completion of the offering remain subject to market conditions, with no guarantees of completion. A preliminary prospectus supplement and accompanying prospectus will be filed with the SEC.

Amesite Inc. (NASDAQ: AMST) announced its participation in the Sidoti January Virtual Investor Conference on January 22-23, 2025, where CEO Dr. Ann Marie Sastry and VP of Sales Brandon Owens will present the company's success with NurseMagic™. The presentation is scheduled for January 22 at 10:45am ET.

NurseMagic™, the company's AI-driven healthcare solution, has achieved significant market penetration since its recent launch, now serving users across 87 different healthcare professions in all 50 US states and 21 countries. The platform supports various healthcare professionals, from registered nurses to healthcare CEOs, and has secured enterprise sales with major home care franchise companies. The solution includes both consumer subscriptions and a HIPAA-compliant enterprise offering.

Amesite Inc. (NASDAQ: AMST) announced the release of an end-of-year video shareholder update scheduled for December 23, 2024, at 3:00 pm ET. The presentation, led by CEO Dr. Ann Marie Sastry, will be accessible on the company's investor relations website. The update will cover key aspects of their NurseMagic™ product, including B2C and B2B offerings, revenue growth, marketing strategies, onboarding processes, and projected profitability metrics. Additionally, the presentation will address the company's infrastructure, user scaling capabilities, and financial position.

Amesite (NASDAQ: AMST) reports significant marketing growth for its NurseMagic™ AI-powered healthcare app. In the past 90 days, the company's social channels achieved remarkable engagement metrics, including 12.7 million account reaches, 550,000 likes, and 400,000 shares. The app, which provides real-time AI support for caregivers, has built a community of 32,000 engaged followers.

Within five months of public launch, NurseMagic™ has secured enterprise contracts with franchise owners, launched paid individual subscriptions, and achieved HIPAA compliance. The company is executing a dual B2B and B2C strategy, supported by testimonials from owners and influencer messaging to drive adoption.